Activity — Foundation Fighting Blindness Retinal Degeneration Fund

1 move.

Date	Action	Company	Value	Shares Δ	Position after	Impact
May 18, 2026	Sell	IRD Opus Genetics, Inc. Common Stock	$7.39M	-1.7M -30.95%	3,792,171 4.56% of shares	medium